Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain zaps and Self-Taught moves: a new way to learn?

NCT ID NCT07197346

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a type of brain stimulation called rTMS, combined with letting people choose when to get feedback, can improve how healthy young adults learn a motor task. 72 participants will be split into groups receiving different types of stimulation or a fake version, then practice tracking a pattern with a joystick. The goal is to understand how these methods affect motivation and learning, not to treat any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 72 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Healthy adults aged 18-35 years 2. Right-handed (per Edinburgh Handedness Inventory) 3. Normal or corrected-to-normal vision and hearing 4. Eligible for non-invasive brain stimulation per safety screening (no contraindications to TMS) 5. Able to understand study procedures and provide written informed consent in Chinese 6. Willing to comply with all study visits and tasks, including TBS/rTMS and motor practice 7. For yoked pairing: able to be matched to a counterpart participant for practice parameters Exclusion Criteria: 1. History of epilepsy, seizures, or unexplained fainting; family history of epilepsy in first-degree relatives 2. Any intracranial metal or implanted medical devices (e.g., cochlear implant, deep brain stimulator, aneurysm clips); non-removable metallic objects in head/neck 3. Cardiac pacemaker or other implanted electronic devices 4. Current or past major neurological or psychiatric disorders (e.g., stroke, traumatic brain injury, multiple sclerosis, major depression, bipolar disorder, schizophrenia) 5. Current use of medications lowering seizure threshold or affecting cortical excitability (e.g., tricyclic antidepressants, bupropion, clozapine, lithium, stimulant or sedative-hypnotic abuse); or unstable psychotropic regimens 6. Active migraine with aura or chronic severe headaches 7. Pregnancy or planning pregnancy during participation; breastfeeding (if your site policy excludes) 8. Substance or alcohol use disorder within the past 12 months; positive alcohol/drug screen on visit days 9. Sleep deprivation (\<5 hours) on the day before stimulation, or excessive caffeine (\>400 mg) within 6 hours pre-stimulation 10. Dermatologic conditions or open wounds at stimulation or EMG/electrode sites 11. Prior extensive training on the specific motor task used in this study (risk of ceiling effects) 12. Concurrent participation in another interventional study or received brain stimulation (TMS/tDCS) within the past 3 months 13. Any condition that, in the investigator's judgment, makes participation unsafe or data unreliable

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autonomy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • National Taiwan University Hospital

    RECRUITING

    Taipei, 100, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.